Funder
National Natural Science Foundation of China
Henan Province Novel Coronavirus Control and Prevention Emergency Science and Technology Tackling Key Project
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Ren, Z. et al. A randomized, open-Label, controlled clinical trial of Azvudine tablets in the treatment of mild and common COVID-19, a pilot study. Adv. Sci. 2001435 (2020).
2. Duan, Y. et al. Current and future therapeutical approaches for COVID-19. Drug Discov. Today 25, 1545–1552 (2020).
3. Beigel, J. H. et al. Remdesivir for the treatment of Covid-19—preliminary report. N. Engl. J. Med. NEJMoa2007764 (2020).
4. Kuehn, B. M. Genetic analysis tracks SARS-CoV-2 mutations in human hosts. JAMA 323, 2363 (2020).
5. Sun, L. et al. Mechanistic insight into antiretroviral potency of 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a long-lasting effect on HIV-1 prevention. J. Med. Chem. 63, 8554–8566 (2020).
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献